A study reveals stark differences in hepatocellular carcinoma outcomes between South Africa and Sweden, highlighting the need for region-specific treatment protocols.
- Patients in South Africa were significantly younger (median 50 vs. 71 years) and had more advanced disease.
- Only 9.2% received curative treatments in South Africa versus 42.5% in Sweden.
Survival rates were drastically lower: 1-year survival was 17.8% in South Africa compared to 58.9% in Sweden.
Tailored clinical guidelines are crucial to improve patient outcomes in lower-income regions.
Journal Article by Sobnach S, Bayadsi H (…) Jonas E et 10 al. in Br J Surg
© The Author(s) 2026. Published by Oxford University Press on behalf of BJS Foundation Ltd.